Analyst Ratings for Rocket Pharmaceuticals (RCKT)
RCKT Rating Summary
RCKT Price Target Summary
- Highest: $32.00 (Wedbush)
- Lowest: $2.00 (Goldman Sachs)
- Average: $12.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$12.88 (+307.7%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 65%
Avg. $ Target:
$12.88 (+307.7%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 65%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/30/2025 | Evercore ISI | Joshua Schimmer | Downgrade | In Line (Outperform) |
5.00 (18.00) |
2.62 (3.16) |
20.61% | Details |
| 5/28/2025 | JPMorgan | Eric Joseph | Downgrade | Neutral (Overweight) |
7.00 (44.00) |
2.33 (3.16) |
35.62% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
